Last reviewed · How we verify
NCT06969885
Effect of Virtual Reality Glasses on Stress, Muscle Tension, and Physiological Parameters Before Angiography
NA trial testing Intervention application with virtual reality glasses in Coronary Angiography (CAG) in 60 participants. Not yet recruiting.
1 October 2025
Quick facts
| Lead sponsor | Yuksek Ihtisas University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 July 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Intervention application with virtual reality glasses
- Standard application
Conditions studied
- Coronary Angiography (CAG) — all drugs for Coronary Angiography (CAG) →
Sponsor
Yuksek Ihtisas University
Who can join
Adults 18 to 65, any sex, with Coronary Angiography (CAG). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Today, cardiovascular diseases are the leading cause of morbidity and mortality worldwide. Coronary angiography (CAG), a commonly used invasive procedure for diagnosing coronary artery disease, may trigger fear, stress, and anxiety in patients due to its invasive nature, lack of information, uncertainty, and the possibility of receiving a life-threatening diagnosis.These emotional responses activate stress mechanisms, leading to catecholamine release, increased heart rate, blood pressure, respiration, sweating, and muscle tension. Elevated stress can also cause lactic acid accumulation, increased oxygen demand, and muscular contraction, potentially resulting in coronary artery spasms or arrhythmias, and increasing procedural risks. Therefore, reducing stress before CAG is crucial to improving procedural outcomes and patient recovery. To address preoperative anxiety and stress, both pharmacologic and non-pharmacologic interventions are used. Among the non-pharmacologic options, virtual reality (VR) has emerged as an effective method to distract and calm patients, reducing anxiety, stress, and pain. Studies in various patient populations suggest VR glasses can be beneficial in managing psychological distress. However, no study has been found in the literature evaluating the effect of VR on stress-induced muscle tension in patients undergoing CAG. This gap highlights the potential contribution of this study to current knowledge. This study aims to investigate the effect of using VR glasses before coronary angiography on patients' stress levels, muscle tension, and selected physiological parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06969885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Yuksek Ihtisas University trials
Trials by the same sponsor.
- NCT07278219 — Balint Approach Group Intervention · NA · completed
- NCT06542185 — Self-Efficacy Levels of Nurses on Safe Blood and Blood Product Transfusion · NA · completed
- NCT06354517 — The Impact of the SENSE Program on NICU · NA · not yet recruiting
- NCT05839743 — Investigation of the Effects of Aerobic Exercise, Balance Exercise and Combined Exercise Practices on Frailty, Balance, · NA · completed
- NCT05997550 — The Effect of Pursed Lip Breathing Exercise and Laughter Therapy Individuals With The COPD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06969885 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuksek Ihtisas University
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06969885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing